Perceptive Advisors LLC

Orchestra BioMed Holdings, Inc. · 10% Owner

Perceptive Advisors LLC is listed in public filings as 10 percent owner. This Perceptive Advisors LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Orchestra BioMed Holdings, Inc. (OBIO), Nautilus Biotechnology, Inc. (NAUT), MeiraGTx Holdings plc (MGTX), Lyra Therapeutics, Inc. (LYRA), and LeonaBio, Inc. (LONA). Investors use Perceptive Advisors LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Orchestra BioMed Holdings, Inc.OBIO$1501.5M sharesBuyAug 1, 2025$0.0001--
Orchestra BioMed Holdings, Inc.OBIO$1.9M700k sharesBuyAug 1, 2025$2.75--
MeiraGTx Holdings plcMGTX$5.0M1.3M sharesBuyAug 12, 2024$4.00--
Lyra Therapeutics, Inc.LYRA$8.5k1.9k sharesSellNov 10, 2025$4.54--
Lyra Therapeutics, Inc.LYRA$9.5k2k sharesSellNov 7, 2025$4.75--
Lyra Therapeutics, Inc.LYRA$17k3.2k sharesSellNov 6, 2025$5.18--
Lyra Therapeutics, Inc.LYRA$76k16.6k sharesSellNov 10, 2025$4.54--
Lyra Therapeutics, Inc.LYRA$84k17.7k sharesSellNov 7, 2025$4.75--
Lyra Therapeutics, Inc.LYRA$150k28.9k sharesSellNov 6, 2025$5.18--
Lyra Therapeutics, Inc.LYRA$3.6k883 sharesSellNov 12, 2025$4.06--
Lyra Therapeutics, Inc.LYRA$2.3k537 sharesSellNov 11, 2025$4.31--
Lyra Therapeutics, Inc.LYRA$32k7.9k sharesSellNov 12, 2025$4.06--
Lyra Therapeutics, Inc.LYRA$21k4.8k sharesSellNov 11, 2025$4.31--
Aldeyra Therapeutics, Inc.ALDX$4.8M3.4M sharesSellApr 3, 2025$1.42--
Adagio Medical Holdings, Inc.ADGM$2.3M1.3M sharesBuyOct 20, 2025$1.71--
Adagio Medical Holdings, Inc.ADGM$2192.2M sharesBuyOct 20, 2025$0.0001--
Acrivon Therapeutics, Inc. Common StockACRV$353k250k sharesSellApr 29, 2025$1.41--
Acrivon Therapeutics, Inc. Common StockACRV$336k215.3k sharesSellApr 28, 2025$1.56--
Acrivon Therapeutics, Inc. Common StockACRV$2.1M1.1M sharesSellApr 25, 2025$1.95--
Acrivon Therapeutics, Inc. Common StockACRV$401k298.9k sharesSellMay 1, 2025$1.34--
Acrivon Therapeutics, Inc. Common StockACRV$617k437.9k sharesSellApr 30, 2025$1.41--
Perceptive Advisors LLC History Trades | TradingNote